Global VMAT2 Inhibitors Supply, Demand and Key Producers, 2023-2029
The global VMAT2 Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Vesicular monoamine transporter-2 is the transmembrane protein which is primarily responsible for the transport of monoamines neurotransmitters such as histamines, serotonin, dopamine, and norepinephrine into the synaptic vesicles. VMAT2 transporter carries the cytoplasmic dopamine into the vesicles. VMAT2 inhibitors reduce the dopamine at the presynaptic striatal nerve terminals and decrease unwanted body movements for these conditions. VMAT2 inhibitors are widely used to treat uncontrollable involuntary, repetitive body movements caused by tardive dyskinesia and Huntington’s disease.
This report studies the global VMAT2 Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for VMAT2 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of VMAT2 Inhibitors that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global VMAT2 Inhibitors total production and demand, 2018-2029, (K Units)
Global VMAT2 Inhibitors total production value, 2018-2029, (USD Million)
Global VMAT2 Inhibitors production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global VMAT2 Inhibitors consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: VMAT2 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global VMAT2 Inhibitors production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global VMAT2 Inhibitors production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global VMAT2 Inhibitors production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global VMAT2 Inhibitors market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Neurocrine Biosciences, Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Hikma Pharmaceuticals plc, Hetero, Bausch Health Companies Inc, Dr. Reddy's Laboratories Ltd, Piramal Pharma Solution and Lupin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World VMAT2 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global VMAT2 Inhibitors Market, By Region:
1. How big is the global VMAT2 Inhibitors market?
2. What is the demand of the global VMAT2 Inhibitors market?
3. What is the year over year growth of the global VMAT2 Inhibitors market?
4. What is the production and production value of the global VMAT2 Inhibitors market?
5. Who are the key producers in the global VMAT2 Inhibitors market?
6. What are the growth factors driving the market demand?
Vesicular monoamine transporter-2 is the transmembrane protein which is primarily responsible for the transport of monoamines neurotransmitters such as histamines, serotonin, dopamine, and norepinephrine into the synaptic vesicles. VMAT2 transporter carries the cytoplasmic dopamine into the vesicles. VMAT2 inhibitors reduce the dopamine at the presynaptic striatal nerve terminals and decrease unwanted body movements for these conditions. VMAT2 inhibitors are widely used to treat uncontrollable involuntary, repetitive body movements caused by tardive dyskinesia and Huntington’s disease.
This report studies the global VMAT2 Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for VMAT2 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of VMAT2 Inhibitors that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global VMAT2 Inhibitors total production and demand, 2018-2029, (K Units)
Global VMAT2 Inhibitors total production value, 2018-2029, (USD Million)
Global VMAT2 Inhibitors production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global VMAT2 Inhibitors consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: VMAT2 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global VMAT2 Inhibitors production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global VMAT2 Inhibitors production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global VMAT2 Inhibitors production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global VMAT2 Inhibitors market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Neurocrine Biosciences, Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Hikma Pharmaceuticals plc, Hetero, Bausch Health Companies Inc, Dr. Reddy's Laboratories Ltd, Piramal Pharma Solution and Lupin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World VMAT2 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global VMAT2 Inhibitors Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tetrabenazine
- Valbenazine
- Other
- Huntington’s Disease
- Tardive Dyskinesia
- Other
- Neurocrine Biosciences, Inc
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals plc
- Hetero
- Bausch Health Companies Inc
- Dr. Reddy's Laboratories Ltd
- Piramal Pharma Solution
- Lupin
- Luye Pharma Group
1. How big is the global VMAT2 Inhibitors market?
2. What is the demand of the global VMAT2 Inhibitors market?
3. What is the year over year growth of the global VMAT2 Inhibitors market?
4. What is the production and production value of the global VMAT2 Inhibitors market?
5. Who are the key producers in the global VMAT2 Inhibitors market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 VMAT2 Inhibitors Introduction
1.2 World VMAT2 Inhibitors Supply & Forecast
1.2.1 World VMAT2 Inhibitors Production Value (2018 & 2022 & 2029)
1.2.2 World VMAT2 Inhibitors Production (2018-2029)
1.2.3 World VMAT2 Inhibitors Pricing Trends (2018-2029)
1.3 World VMAT2 Inhibitors Production by Region (Based on Production Site)
1.3.1 World VMAT2 Inhibitors Production Value by Region (2018-2029)
1.3.2 World VMAT2 Inhibitors Production by Region (2018-2029)
1.3.3 World VMAT2 Inhibitors Average Price by Region (2018-2029)
1.3.4 North America VMAT2 Inhibitors Production (2018-2029)
1.3.5 Europe VMAT2 Inhibitors Production (2018-2029)
1.3.6 China VMAT2 Inhibitors Production (2018-2029)
1.3.7 Japan VMAT2 Inhibitors Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 VMAT2 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 VMAT2 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World VMAT2 Inhibitors Demand (2018-2029)
2.2 World VMAT2 Inhibitors Consumption by Region
2.2.1 World VMAT2 Inhibitors Consumption by Region (2018-2023)
2.2.2 World VMAT2 Inhibitors Consumption Forecast by Region (2024-2029)
2.3 United States VMAT2 Inhibitors Consumption (2018-2029)
2.4 China VMAT2 Inhibitors Consumption (2018-2029)
2.5 Europe VMAT2 Inhibitors Consumption (2018-2029)
2.6 Japan VMAT2 Inhibitors Consumption (2018-2029)
2.7 South Korea VMAT2 Inhibitors Consumption (2018-2029)
2.8 ASEAN VMAT2 Inhibitors Consumption (2018-2029)
2.9 India VMAT2 Inhibitors Consumption (2018-2029)
3 WORLD VMAT2 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World VMAT2 Inhibitors Production Value by Manufacturer (2018-2023)
3.2 World VMAT2 Inhibitors Production by Manufacturer (2018-2023)
3.3 World VMAT2 Inhibitors Average Price by Manufacturer (2018-2023)
3.4 VMAT2 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global VMAT2 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for VMAT2 Inhibitors in 2022
3.5.3 Global Concentration Ratios (CR8) for VMAT2 Inhibitors in 2022
3.6 VMAT2 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 VMAT2 Inhibitors Market: Region Footprint
3.6.2 VMAT2 Inhibitors Market: Company Product Type Footprint
3.6.3 VMAT2 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: VMAT2 Inhibitors Production Value Comparison
4.1.1 United States VS China: VMAT2 Inhibitors Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: VMAT2 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: VMAT2 Inhibitors Production Comparison
4.2.1 United States VS China: VMAT2 Inhibitors Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: VMAT2 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: VMAT2 Inhibitors Consumption Comparison
4.3.1 United States VS China: VMAT2 Inhibitors Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: VMAT2 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based VMAT2 Inhibitors Manufacturers and Market Share, 2018-2023
4.4.1 United States Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers VMAT2 Inhibitors Production Value (2018-2023)
4.4.3 United States Based Manufacturers VMAT2 Inhibitors Production (2018-2023)
4.5 China Based VMAT2 Inhibitors Manufacturers and Market Share
4.5.1 China Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers VMAT2 Inhibitors Production Value (2018-2023)
4.5.3 China Based Manufacturers VMAT2 Inhibitors Production (2018-2023)
4.6 Rest of World Based VMAT2 Inhibitors Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers VMAT2 Inhibitors Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers VMAT2 Inhibitors Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World VMAT2 Inhibitors Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tetrabenazine
5.2.2 Valbenazine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World VMAT2 Inhibitors Production by Type (2018-2029)
5.3.2 World VMAT2 Inhibitors Production Value by Type (2018-2029)
5.3.3 World VMAT2 Inhibitors Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World VMAT2 Inhibitors Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Huntington’s Disease
6.2.2 Tardive Dyskinesia
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World VMAT2 Inhibitors Production by Application (2018-2029)
6.3.2 World VMAT2 Inhibitors Production Value by Application (2018-2029)
6.3.3 World VMAT2 Inhibitors Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Neurocrine Biosciences, Inc
7.1.1 Neurocrine Biosciences, Inc Details
7.1.2 Neurocrine Biosciences, Inc Major Business
7.1.3 Neurocrine Biosciences, Inc VMAT2 Inhibitors Product and Services
7.1.4 Neurocrine Biosciences, Inc VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Neurocrine Biosciences, Inc Recent Developments/Updates
7.1.6 Neurocrine Biosciences, Inc Competitive Strengths & Weaknesses
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Details
7.2.2 Teva Pharmaceutical Industries Ltd Major Business
7.2.3 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
7.2.4 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.2.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.3 Sun Pharmaceutical Industries Ltd
7.3.1 Sun Pharmaceutical Industries Ltd Details
7.3.2 Sun Pharmaceutical Industries Ltd Major Business
7.3.3 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
7.3.4 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Hikma Pharmaceuticals plc
7.4.1 Hikma Pharmaceuticals plc Details
7.4.2 Hikma Pharmaceuticals plc Major Business
7.4.3 Hikma Pharmaceuticals plc VMAT2 Inhibitors Product and Services
7.4.4 Hikma Pharmaceuticals plc VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
7.4.6 Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
7.5 Hetero
7.5.1 Hetero Details
7.5.2 Hetero Major Business
7.5.3 Hetero VMAT2 Inhibitors Product and Services
7.5.4 Hetero VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Hetero Recent Developments/Updates
7.5.6 Hetero Competitive Strengths & Weaknesses
7.6 Bausch Health Companies Inc
7.6.1 Bausch Health Companies Inc Details
7.6.2 Bausch Health Companies Inc Major Business
7.6.3 Bausch Health Companies Inc VMAT2 Inhibitors Product and Services
7.6.4 Bausch Health Companies Inc VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bausch Health Companies Inc Recent Developments/Updates
7.6.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.7 Dr. Reddy's Laboratories Ltd
7.7.1 Dr. Reddy's Laboratories Ltd Details
7.7.2 Dr. Reddy's Laboratories Ltd Major Business
7.7.3 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Product and Services
7.7.4 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Dr. Reddy's Laboratories Ltd Recent Developments/Updates
7.7.6 Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
7.8 Piramal Pharma Solution
7.8.1 Piramal Pharma Solution Details
7.8.2 Piramal Pharma Solution Major Business
7.8.3 Piramal Pharma Solution VMAT2 Inhibitors Product and Services
7.8.4 Piramal Pharma Solution VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Piramal Pharma Solution Recent Developments/Updates
7.8.6 Piramal Pharma Solution Competitive Strengths & Weaknesses
7.9 Lupin
7.9.1 Lupin Details
7.9.2 Lupin Major Business
7.9.3 Lupin VMAT2 Inhibitors Product and Services
7.9.4 Lupin VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Lupin Recent Developments/Updates
7.9.6 Lupin Competitive Strengths & Weaknesses
7.10 Luye Pharma Group
7.10.1 Luye Pharma Group Details
7.10.2 Luye Pharma Group Major Business
7.10.3 Luye Pharma Group VMAT2 Inhibitors Product and Services
7.10.4 Luye Pharma Group VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Luye Pharma Group Recent Developments/Updates
7.10.6 Luye Pharma Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 VMAT2 Inhibitors Industry Chain
8.2 VMAT2 Inhibitors Upstream Analysis
8.2.1 VMAT2 Inhibitors Core Raw Materials
8.2.2 Main Manufacturers of VMAT2 Inhibitors Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 VMAT2 Inhibitors Production Mode
8.6 VMAT2 Inhibitors Procurement Model
8.7 VMAT2 Inhibitors Industry Sales Model and Sales Channels
8.7.1 VMAT2 Inhibitors Sales Model
8.7.2 VMAT2 Inhibitors Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 VMAT2 Inhibitors Introduction
1.2 World VMAT2 Inhibitors Supply & Forecast
1.2.1 World VMAT2 Inhibitors Production Value (2018 & 2022 & 2029)
1.2.2 World VMAT2 Inhibitors Production (2018-2029)
1.2.3 World VMAT2 Inhibitors Pricing Trends (2018-2029)
1.3 World VMAT2 Inhibitors Production by Region (Based on Production Site)
1.3.1 World VMAT2 Inhibitors Production Value by Region (2018-2029)
1.3.2 World VMAT2 Inhibitors Production by Region (2018-2029)
1.3.3 World VMAT2 Inhibitors Average Price by Region (2018-2029)
1.3.4 North America VMAT2 Inhibitors Production (2018-2029)
1.3.5 Europe VMAT2 Inhibitors Production (2018-2029)
1.3.6 China VMAT2 Inhibitors Production (2018-2029)
1.3.7 Japan VMAT2 Inhibitors Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 VMAT2 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 VMAT2 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World VMAT2 Inhibitors Demand (2018-2029)
2.2 World VMAT2 Inhibitors Consumption by Region
2.2.1 World VMAT2 Inhibitors Consumption by Region (2018-2023)
2.2.2 World VMAT2 Inhibitors Consumption Forecast by Region (2024-2029)
2.3 United States VMAT2 Inhibitors Consumption (2018-2029)
2.4 China VMAT2 Inhibitors Consumption (2018-2029)
2.5 Europe VMAT2 Inhibitors Consumption (2018-2029)
2.6 Japan VMAT2 Inhibitors Consumption (2018-2029)
2.7 South Korea VMAT2 Inhibitors Consumption (2018-2029)
2.8 ASEAN VMAT2 Inhibitors Consumption (2018-2029)
2.9 India VMAT2 Inhibitors Consumption (2018-2029)
3 WORLD VMAT2 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World VMAT2 Inhibitors Production Value by Manufacturer (2018-2023)
3.2 World VMAT2 Inhibitors Production by Manufacturer (2018-2023)
3.3 World VMAT2 Inhibitors Average Price by Manufacturer (2018-2023)
3.4 VMAT2 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global VMAT2 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for VMAT2 Inhibitors in 2022
3.5.3 Global Concentration Ratios (CR8) for VMAT2 Inhibitors in 2022
3.6 VMAT2 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 VMAT2 Inhibitors Market: Region Footprint
3.6.2 VMAT2 Inhibitors Market: Company Product Type Footprint
3.6.3 VMAT2 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: VMAT2 Inhibitors Production Value Comparison
4.1.1 United States VS China: VMAT2 Inhibitors Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: VMAT2 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: VMAT2 Inhibitors Production Comparison
4.2.1 United States VS China: VMAT2 Inhibitors Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: VMAT2 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: VMAT2 Inhibitors Consumption Comparison
4.3.1 United States VS China: VMAT2 Inhibitors Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: VMAT2 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based VMAT2 Inhibitors Manufacturers and Market Share, 2018-2023
4.4.1 United States Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers VMAT2 Inhibitors Production Value (2018-2023)
4.4.3 United States Based Manufacturers VMAT2 Inhibitors Production (2018-2023)
4.5 China Based VMAT2 Inhibitors Manufacturers and Market Share
4.5.1 China Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers VMAT2 Inhibitors Production Value (2018-2023)
4.5.3 China Based Manufacturers VMAT2 Inhibitors Production (2018-2023)
4.6 Rest of World Based VMAT2 Inhibitors Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers VMAT2 Inhibitors Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers VMAT2 Inhibitors Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World VMAT2 Inhibitors Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tetrabenazine
5.2.2 Valbenazine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World VMAT2 Inhibitors Production by Type (2018-2029)
5.3.2 World VMAT2 Inhibitors Production Value by Type (2018-2029)
5.3.3 World VMAT2 Inhibitors Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World VMAT2 Inhibitors Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Huntington’s Disease
6.2.2 Tardive Dyskinesia
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World VMAT2 Inhibitors Production by Application (2018-2029)
6.3.2 World VMAT2 Inhibitors Production Value by Application (2018-2029)
6.3.3 World VMAT2 Inhibitors Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Neurocrine Biosciences, Inc
7.1.1 Neurocrine Biosciences, Inc Details
7.1.2 Neurocrine Biosciences, Inc Major Business
7.1.3 Neurocrine Biosciences, Inc VMAT2 Inhibitors Product and Services
7.1.4 Neurocrine Biosciences, Inc VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Neurocrine Biosciences, Inc Recent Developments/Updates
7.1.6 Neurocrine Biosciences, Inc Competitive Strengths & Weaknesses
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Details
7.2.2 Teva Pharmaceutical Industries Ltd Major Business
7.2.3 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
7.2.4 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.2.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.3 Sun Pharmaceutical Industries Ltd
7.3.1 Sun Pharmaceutical Industries Ltd Details
7.3.2 Sun Pharmaceutical Industries Ltd Major Business
7.3.3 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
7.3.4 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Hikma Pharmaceuticals plc
7.4.1 Hikma Pharmaceuticals plc Details
7.4.2 Hikma Pharmaceuticals plc Major Business
7.4.3 Hikma Pharmaceuticals plc VMAT2 Inhibitors Product and Services
7.4.4 Hikma Pharmaceuticals plc VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
7.4.6 Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
7.5 Hetero
7.5.1 Hetero Details
7.5.2 Hetero Major Business
7.5.3 Hetero VMAT2 Inhibitors Product and Services
7.5.4 Hetero VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Hetero Recent Developments/Updates
7.5.6 Hetero Competitive Strengths & Weaknesses
7.6 Bausch Health Companies Inc
7.6.1 Bausch Health Companies Inc Details
7.6.2 Bausch Health Companies Inc Major Business
7.6.3 Bausch Health Companies Inc VMAT2 Inhibitors Product and Services
7.6.4 Bausch Health Companies Inc VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bausch Health Companies Inc Recent Developments/Updates
7.6.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.7 Dr. Reddy's Laboratories Ltd
7.7.1 Dr. Reddy's Laboratories Ltd Details
7.7.2 Dr. Reddy's Laboratories Ltd Major Business
7.7.3 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Product and Services
7.7.4 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Dr. Reddy's Laboratories Ltd Recent Developments/Updates
7.7.6 Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
7.8 Piramal Pharma Solution
7.8.1 Piramal Pharma Solution Details
7.8.2 Piramal Pharma Solution Major Business
7.8.3 Piramal Pharma Solution VMAT2 Inhibitors Product and Services
7.8.4 Piramal Pharma Solution VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Piramal Pharma Solution Recent Developments/Updates
7.8.6 Piramal Pharma Solution Competitive Strengths & Weaknesses
7.9 Lupin
7.9.1 Lupin Details
7.9.2 Lupin Major Business
7.9.3 Lupin VMAT2 Inhibitors Product and Services
7.9.4 Lupin VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Lupin Recent Developments/Updates
7.9.6 Lupin Competitive Strengths & Weaknesses
7.10 Luye Pharma Group
7.10.1 Luye Pharma Group Details
7.10.2 Luye Pharma Group Major Business
7.10.3 Luye Pharma Group VMAT2 Inhibitors Product and Services
7.10.4 Luye Pharma Group VMAT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Luye Pharma Group Recent Developments/Updates
7.10.6 Luye Pharma Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 VMAT2 Inhibitors Industry Chain
8.2 VMAT2 Inhibitors Upstream Analysis
8.2.1 VMAT2 Inhibitors Core Raw Materials
8.2.2 Main Manufacturers of VMAT2 Inhibitors Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 VMAT2 Inhibitors Production Mode
8.6 VMAT2 Inhibitors Procurement Model
8.7 VMAT2 Inhibitors Industry Sales Model and Sales Channels
8.7.1 VMAT2 Inhibitors Sales Model
8.7.2 VMAT2 Inhibitors Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World VMAT2 Inhibitors Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World VMAT2 Inhibitors Production Value by Region (2018-2023) & (USD Million)
Table 3. World VMAT2 Inhibitors Production Value by Region (2024-2029) & (USD Million)
Table 4. World VMAT2 Inhibitors Production Value Market Share by Region (2018-2023)
Table 5. World VMAT2 Inhibitors Production Value Market Share by Region (2024-2029)
Table 6. World VMAT2 Inhibitors Production by Region (2018-2023) & (K Units)
Table 7. World VMAT2 Inhibitors Production by Region (2024-2029) & (K Units)
Table 8. World VMAT2 Inhibitors Production Market Share by Region (2018-2023)
Table 9. World VMAT2 Inhibitors Production Market Share by Region (2024-2029)
Table 10. World VMAT2 Inhibitors Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World VMAT2 Inhibitors Average Price by Region (2024-2029) & (US$/Unit)
Table 12. VMAT2 Inhibitors Major Market Trends
Table 13. World VMAT2 Inhibitors Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World VMAT2 Inhibitors Consumption by Region (2018-2023) & (K Units)
Table 15. World VMAT2 Inhibitors Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World VMAT2 Inhibitors Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key VMAT2 Inhibitors Producers in 2022
Table 18. World VMAT2 Inhibitors Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key VMAT2 Inhibitors Producers in 2022
Table 20. World VMAT2 Inhibitors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global VMAT2 Inhibitors Company Evaluation Quadrant
Table 22. World VMAT2 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and VMAT2 Inhibitors Production Site of Key Manufacturer
Table 24. VMAT2 Inhibitors Market: Company Product Type Footprint
Table 25. VMAT2 Inhibitors Market: Company Product Application Footprint
Table 26. VMAT2 Inhibitors Competitive Factors
Table 27. VMAT2 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. VMAT2 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China VMAT2 Inhibitors Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China VMAT2 Inhibitors Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China VMAT2 Inhibitors Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers VMAT2 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers VMAT2 Inhibitors Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers VMAT2 Inhibitors Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers VMAT2 Inhibitors Production Market Share (2018-2023)
Table 37. China Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers VMAT2 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers VMAT2 Inhibitors Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers VMAT2 Inhibitors Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers VMAT2 Inhibitors Production Market Share (2018-2023)
Table 42. Rest of World Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers VMAT2 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers VMAT2 Inhibitors Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers VMAT2 Inhibitors Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers VMAT2 Inhibitors Production Market Share (2018-2023)
Table 47. World VMAT2 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World VMAT2 Inhibitors Production by Type (2018-2023) & (K Units)
Table 49. World VMAT2 Inhibitors Production by Type (2024-2029) & (K Units)
Table 50. World VMAT2 Inhibitors Production Value by Type (2018-2023) & (USD Million)
Table 51. World VMAT2 Inhibitors Production Value by Type (2024-2029) & (USD Million)
Table 52. World VMAT2 Inhibitors Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World VMAT2 Inhibitors Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World VMAT2 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World VMAT2 Inhibitors Production by Application (2018-2023) & (K Units)
Table 56. World VMAT2 Inhibitors Production by Application (2024-2029) & (K Units)
Table 57. World VMAT2 Inhibitors Production Value by Application (2018-2023) & (USD Million)
Table 58. World VMAT2 Inhibitors Production Value by Application (2024-2029) & (USD Million)
Table 59. World VMAT2 Inhibitors Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World VMAT2 Inhibitors Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Neurocrine Biosciences, Inc Basic Information, Manufacturing Base and Competitors
Table 62. Neurocrine Biosciences, Inc Major Business
Table 63. Neurocrine Biosciences, Inc VMAT2 Inhibitors Product and Services
Table 64. Neurocrine Biosciences, Inc VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Neurocrine Biosciences, Inc Recent Developments/Updates
Table 66. Neurocrine Biosciences, Inc Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical Industries Ltd Major Business
Table 69. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
Table 70. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 72. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 73. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharmaceutical Industries Ltd Major Business
Table 75. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
Table 76. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Hikma Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Pharmaceuticals plc Major Business
Table 81. Hikma Pharmaceuticals plc VMAT2 Inhibitors Product and Services
Table 82. Hikma Pharmaceuticals plc VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 84. Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
Table 85. Hetero Basic Information, Manufacturing Base and Competitors
Table 86. Hetero Major Business
Table 87. Hetero VMAT2 Inhibitors Product and Services
Table 88. Hetero VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Hetero Recent Developments/Updates
Table 90. Hetero Competitive Strengths & Weaknesses
Table 91. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Companies Inc Major Business
Table 93. Bausch Health Companies Inc VMAT2 Inhibitors Product and Services
Table 94. Bausch Health Companies Inc VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bausch Health Companies Inc Recent Developments/Updates
Table 96. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 97. Dr. Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Dr. Reddy's Laboratories Ltd Major Business
Table 99. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Product and Services
Table 100. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Dr. Reddy's Laboratories Ltd Recent Developments/Updates
Table 102. Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
Table 103. Piramal Pharma Solution Basic Information, Manufacturing Base and Competitors
Table 104. Piramal Pharma Solution Major Business
Table 105. Piramal Pharma Solution VMAT2 Inhibitors Product and Services
Table 106. Piramal Pharma Solution VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Piramal Pharma Solution Recent Developments/Updates
Table 108. Piramal Pharma Solution Competitive Strengths & Weaknesses
Table 109. Lupin Basic Information, Manufacturing Base and Competitors
Table 110. Lupin Major Business
Table 111. Lupin VMAT2 Inhibitors Product and Services
Table 112. Lupin VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Lupin Recent Developments/Updates
Table 114. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 115. Luye Pharma Group Major Business
Table 116. Luye Pharma Group VMAT2 Inhibitors Product and Services
Table 117. Luye Pharma Group VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of VMAT2 Inhibitors Upstream (Raw Materials)
Table 119. VMAT2 Inhibitors Typical Customers
Table 120. VMAT2 Inhibitors Typical Distributors
Table 1. World VMAT2 Inhibitors Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World VMAT2 Inhibitors Production Value by Region (2018-2023) & (USD Million)
Table 3. World VMAT2 Inhibitors Production Value by Region (2024-2029) & (USD Million)
Table 4. World VMAT2 Inhibitors Production Value Market Share by Region (2018-2023)
Table 5. World VMAT2 Inhibitors Production Value Market Share by Region (2024-2029)
Table 6. World VMAT2 Inhibitors Production by Region (2018-2023) & (K Units)
Table 7. World VMAT2 Inhibitors Production by Region (2024-2029) & (K Units)
Table 8. World VMAT2 Inhibitors Production Market Share by Region (2018-2023)
Table 9. World VMAT2 Inhibitors Production Market Share by Region (2024-2029)
Table 10. World VMAT2 Inhibitors Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World VMAT2 Inhibitors Average Price by Region (2024-2029) & (US$/Unit)
Table 12. VMAT2 Inhibitors Major Market Trends
Table 13. World VMAT2 Inhibitors Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World VMAT2 Inhibitors Consumption by Region (2018-2023) & (K Units)
Table 15. World VMAT2 Inhibitors Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World VMAT2 Inhibitors Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key VMAT2 Inhibitors Producers in 2022
Table 18. World VMAT2 Inhibitors Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key VMAT2 Inhibitors Producers in 2022
Table 20. World VMAT2 Inhibitors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global VMAT2 Inhibitors Company Evaluation Quadrant
Table 22. World VMAT2 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and VMAT2 Inhibitors Production Site of Key Manufacturer
Table 24. VMAT2 Inhibitors Market: Company Product Type Footprint
Table 25. VMAT2 Inhibitors Market: Company Product Application Footprint
Table 26. VMAT2 Inhibitors Competitive Factors
Table 27. VMAT2 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. VMAT2 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China VMAT2 Inhibitors Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China VMAT2 Inhibitors Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China VMAT2 Inhibitors Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers VMAT2 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers VMAT2 Inhibitors Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers VMAT2 Inhibitors Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers VMAT2 Inhibitors Production Market Share (2018-2023)
Table 37. China Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers VMAT2 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers VMAT2 Inhibitors Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers VMAT2 Inhibitors Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers VMAT2 Inhibitors Production Market Share (2018-2023)
Table 42. Rest of World Based VMAT2 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers VMAT2 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers VMAT2 Inhibitors Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers VMAT2 Inhibitors Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers VMAT2 Inhibitors Production Market Share (2018-2023)
Table 47. World VMAT2 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World VMAT2 Inhibitors Production by Type (2018-2023) & (K Units)
Table 49. World VMAT2 Inhibitors Production by Type (2024-2029) & (K Units)
Table 50. World VMAT2 Inhibitors Production Value by Type (2018-2023) & (USD Million)
Table 51. World VMAT2 Inhibitors Production Value by Type (2024-2029) & (USD Million)
Table 52. World VMAT2 Inhibitors Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World VMAT2 Inhibitors Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World VMAT2 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World VMAT2 Inhibitors Production by Application (2018-2023) & (K Units)
Table 56. World VMAT2 Inhibitors Production by Application (2024-2029) & (K Units)
Table 57. World VMAT2 Inhibitors Production Value by Application (2018-2023) & (USD Million)
Table 58. World VMAT2 Inhibitors Production Value by Application (2024-2029) & (USD Million)
Table 59. World VMAT2 Inhibitors Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World VMAT2 Inhibitors Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Neurocrine Biosciences, Inc Basic Information, Manufacturing Base and Competitors
Table 62. Neurocrine Biosciences, Inc Major Business
Table 63. Neurocrine Biosciences, Inc VMAT2 Inhibitors Product and Services
Table 64. Neurocrine Biosciences, Inc VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Neurocrine Biosciences, Inc Recent Developments/Updates
Table 66. Neurocrine Biosciences, Inc Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical Industries Ltd Major Business
Table 69. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
Table 70. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 72. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 73. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharmaceutical Industries Ltd Major Business
Table 75. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Product and Services
Table 76. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Hikma Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Pharmaceuticals plc Major Business
Table 81. Hikma Pharmaceuticals plc VMAT2 Inhibitors Product and Services
Table 82. Hikma Pharmaceuticals plc VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 84. Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
Table 85. Hetero Basic Information, Manufacturing Base and Competitors
Table 86. Hetero Major Business
Table 87. Hetero VMAT2 Inhibitors Product and Services
Table 88. Hetero VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Hetero Recent Developments/Updates
Table 90. Hetero Competitive Strengths & Weaknesses
Table 91. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Companies Inc Major Business
Table 93. Bausch Health Companies Inc VMAT2 Inhibitors Product and Services
Table 94. Bausch Health Companies Inc VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bausch Health Companies Inc Recent Developments/Updates
Table 96. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 97. Dr. Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Dr. Reddy's Laboratories Ltd Major Business
Table 99. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Product and Services
Table 100. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Dr. Reddy's Laboratories Ltd Recent Developments/Updates
Table 102. Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
Table 103. Piramal Pharma Solution Basic Information, Manufacturing Base and Competitors
Table 104. Piramal Pharma Solution Major Business
Table 105. Piramal Pharma Solution VMAT2 Inhibitors Product and Services
Table 106. Piramal Pharma Solution VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Piramal Pharma Solution Recent Developments/Updates
Table 108. Piramal Pharma Solution Competitive Strengths & Weaknesses
Table 109. Lupin Basic Information, Manufacturing Base and Competitors
Table 110. Lupin Major Business
Table 111. Lupin VMAT2 Inhibitors Product and Services
Table 112. Lupin VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Lupin Recent Developments/Updates
Table 114. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 115. Luye Pharma Group Major Business
Table 116. Luye Pharma Group VMAT2 Inhibitors Product and Services
Table 117. Luye Pharma Group VMAT2 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of VMAT2 Inhibitors Upstream (Raw Materials)
Table 119. VMAT2 Inhibitors Typical Customers
Table 120. VMAT2 Inhibitors Typical Distributors
LIST OF FIGURES
Figure 1. VMAT2 Inhibitors Picture
Figure 2. World VMAT2 Inhibitors Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World VMAT2 Inhibitors Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 5. World VMAT2 Inhibitors Average Price (2018-2029) & (US$/Unit)
Figure 6. World VMAT2 Inhibitors Production Value Market Share by Region (2018-2029)
Figure 7. World VMAT2 Inhibitors Production Market Share by Region (2018-2029)
Figure 8. North America VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 9. Europe VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 10. China VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 11. Japan VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 12. VMAT2 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 15. World VMAT2 Inhibitors Consumption Market Share by Region (2018-2029)
Figure 16. United States VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 17. China VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 18. Europe VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 19. Japan VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 20. South Korea VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 21. ASEAN VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 22. India VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of VMAT2 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for VMAT2 Inhibitors Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for VMAT2 Inhibitors Markets in 2022
Figure 26. United States VS China: VMAT2 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: VMAT2 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: VMAT2 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers VMAT2 Inhibitors Production Market Share 2022
Figure 30. China Based Manufacturers VMAT2 Inhibitors Production Market Share 2022
Figure 31. Rest of World Based Manufacturers VMAT2 Inhibitors Production Market Share 2022
Figure 32. World VMAT2 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World VMAT2 Inhibitors Production Value Market Share by Type in 2022
Figure 34. Tetrabenazine
Figure 35. Valbenazine
Figure 36. Other
Figure 37. World VMAT2 Inhibitors Production Market Share by Type (2018-2029)
Figure 38. World VMAT2 Inhibitors Production Value Market Share by Type (2018-2029)
Figure 39. World VMAT2 Inhibitors Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World VMAT2 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World VMAT2 Inhibitors Production Value Market Share by Application in 2022
Figure 42. Huntington’s Disease
Figure 43. Tardive Dyskinesia
Figure 44. Other
Figure 45. World VMAT2 Inhibitors Production Market Share by Application (2018-2029)
Figure 46. World VMAT2 Inhibitors Production Value Market Share by Application (2018-2029)
Figure 47. World VMAT2 Inhibitors Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. VMAT2 Inhibitors Industry Chain
Figure 49. VMAT2 Inhibitors Procurement Model
Figure 50. VMAT2 Inhibitors Sales Model
Figure 51. VMAT2 Inhibitors Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. VMAT2 Inhibitors Picture
Figure 2. World VMAT2 Inhibitors Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World VMAT2 Inhibitors Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 5. World VMAT2 Inhibitors Average Price (2018-2029) & (US$/Unit)
Figure 6. World VMAT2 Inhibitors Production Value Market Share by Region (2018-2029)
Figure 7. World VMAT2 Inhibitors Production Market Share by Region (2018-2029)
Figure 8. North America VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 9. Europe VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 10. China VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 11. Japan VMAT2 Inhibitors Production (2018-2029) & (K Units)
Figure 12. VMAT2 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 15. World VMAT2 Inhibitors Consumption Market Share by Region (2018-2029)
Figure 16. United States VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 17. China VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 18. Europe VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 19. Japan VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 20. South Korea VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 21. ASEAN VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 22. India VMAT2 Inhibitors Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of VMAT2 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for VMAT2 Inhibitors Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for VMAT2 Inhibitors Markets in 2022
Figure 26. United States VS China: VMAT2 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: VMAT2 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: VMAT2 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers VMAT2 Inhibitors Production Market Share 2022
Figure 30. China Based Manufacturers VMAT2 Inhibitors Production Market Share 2022
Figure 31. Rest of World Based Manufacturers VMAT2 Inhibitors Production Market Share 2022
Figure 32. World VMAT2 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World VMAT2 Inhibitors Production Value Market Share by Type in 2022
Figure 34. Tetrabenazine
Figure 35. Valbenazine
Figure 36. Other
Figure 37. World VMAT2 Inhibitors Production Market Share by Type (2018-2029)
Figure 38. World VMAT2 Inhibitors Production Value Market Share by Type (2018-2029)
Figure 39. World VMAT2 Inhibitors Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World VMAT2 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World VMAT2 Inhibitors Production Value Market Share by Application in 2022
Figure 42. Huntington’s Disease
Figure 43. Tardive Dyskinesia
Figure 44. Other
Figure 45. World VMAT2 Inhibitors Production Market Share by Application (2018-2029)
Figure 46. World VMAT2 Inhibitors Production Value Market Share by Application (2018-2029)
Figure 47. World VMAT2 Inhibitors Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. VMAT2 Inhibitors Industry Chain
Figure 49. VMAT2 Inhibitors Procurement Model
Figure 50. VMAT2 Inhibitors Sales Model
Figure 51. VMAT2 Inhibitors Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
